All News
Physician Visit Times Vary Worldwide
A metanalysis published in BMJ Open shows that for half of the world’s population, primary care doctor visits last less than five minutes and that the range is from 48 seconds in Bangladesh to 22.5 minutes in Sweden (US PCP visit averages at 20 minutes).
Read Article
Surgical Decompression Ineffective for Subacromial Shoulder Pain
Lancet reports that a common surgical intervention, arthroscopic sub-acromial decompression is ineffective compared to arthroscopy or no surgery at all.
Read Article
RheumNow ACR 2017 Awards
The Annual Meeting of the American College of Rheumatology is a gargantuan educational and professional event that is on nearly everyone's radar each year. RheumNow had an expansive effort to cover this meeting and you can review the work of our faculty at ACR17.RheumNow.com. But we have decided to take this one step further and today we are announcing our 2017 RheumNow ACR Awards.
Read Article
ACR Award Recipients 2017
The American College of Rheumatology opened the 2017 meeting by inducting the new president (Dr. David Daikh) and officers and announcing its 2017 Award Winners. These recognitions are given annually to members who exhibit outstanding contributions to the field of rheumatology.
Read Article
The RheumNow Week in Review - 17 November 2017
Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com. This week he covers FDA warnings on gout drugs, steroid use in Australia, biosimilars lost savings and methotrexate hepatotoxicity in psoriatic arthritis (PsA).
Read Article
DEA Cracks Down on Illicit Fentanyl
Reuters reports that U.S. Drug Enforcement Administration (DEA) has declaed it would classify illicit versions of fentanyl at the same level as heroin, allowing criminal prosecution of anyone who possesses, distributes or manufactures illicit versions of the drug.
Read Article
Good News from ACR17 - Gout
The following is a collection of gout-specific mentions culled from RheumNow's coverage of the Annual ACR 2017 meeting in San Diego.
Read Article
Podcast of ACR17 - Day 4
Care to learn what you missed at last weeks ACR 2017 meeting in San Diego? Here are 4 one hour audio podcasts - each with a compliation of 2-4 minute reports from Drs. Cush, Kavanaugh, the RheumNow Faculty and other rheumatology thought leaders and researchers. Another good way to learn from RheumNow.
Read Article
The ACR17 RheumNow Week in Review - 10 November 2017
This special edition of the RheumNow Week in Review covers highlights of selected sessions from the 2017 ACR annual meeting in San Diego. Dr.
Read Article
Podcast of ACR 17 - Day 3
Check out this compilation of our ACR17 Day 3 broadcasts, merged into a single one hour podcast !
Read Article
Several Agents Score on Radiographic Progression in Psoriatic Arthritis
Reduction on radiographic progression has now become the standard of care in the therapies used to treat psoriatic arthritis and, during the 2017 ACR Meeting, several agents reported the results of their studies with radiographic endpoints.
Read Article
ACR 2017 - Day 3 and 4 Highlights
Day 3 at the annual meeting was rich with information. Yet the most anticipated and best attended session was the Late Breaking Abstracts and the session revealing the new ACR/NPF Guidelines for Psoriatic Arthritis (more on the latter in another report). Day 4 was full of review sessions and a modicum of original content and for me, the 7:30AM Rheumatology Roundup.
Read Article
My ACR Takeaways
With ACR 2017 winding down and the sheer volume of information seemingly overwhelming, I wanted to take the time to write an article regarding a few tips I learned that I will use in clinical practice.
Health Economics of SLE
A number of presentations over the past few days have addressed the health economics of SLE.
Read Article
Practice Patterns of PJP Prophylaxis Among ID Physicians
While the incidence of pneumocystis pneumonia (PJP) is low is patients with rheumatologic diseases the mortality is quite high compared to PJP in patients with HIV and infection can be prevented with appropriate prophylaxis.
Read Article
Cardiovascular Events: Allopurinol vs. Febuxostat
In the registration trials for febuxostat there were concerns about a cardiovascular (CV) safety signal. In studies of the effect of allopurinol on CV risk/events allopurinol has found to be protective so whether febuxostat is different is a point to clarify.
Read Article
EULAR/ACR SLE Classification Criteria Update
Today the draft of the new EULAR/ACR lupus classification criteria was presented at the ACR 2017.
Read Article
Comparative Risk of Biologic Therapies in RA Patients Undergoing Elective Arthroplasty
During today’s plenary session Micheal D. George, et al. presented results of a study that sought to compare risk of post-op infections in RA patients undergoing arthroplasty exposed to biologic DMARDs versus methotrexate.
Read Article
2017 MIPs Reporting, What You Need to Know
As a follow up to Dr. Will Harvey’s lecture at ACR 2017 (session title: Holy MACRA! How to Survive and Thrive in the New Era of MACRA, MIPS, and APMs), here are the keys for reporting your collections.
Read Article
